UnratedDrug recall · FDA · Published December 14, 2018
Results RNA recalls Lubrisine eye drops due to undeclared colloidal silver
Results RNA recalls Lubrisine eye drops (30mL) after finding undeclared colloidal silver. This poses a lack of sterility and potential health risks. Consumers should check their bottles and contact the company for details.
“Results RNA recalls Lubrisine eye drops due to undeclared colloidal silver.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39369-results-rna-recalls-lubrisine-eye-drops-due-to-undeclared-colloidal. Based on FDA recall #D-0360-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0360-2019%22&limit=1).
The FDA announced on December 14, 2018, that Results RNA, LLC voluntarily recalled Lubrisine eye drops due to a lack of sterility assurance and the presence of undeclared colloidal silver. The agency classified the recall as Class I.
How to tell if you have it
Brand: Results RNA
Product: Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle
UPC: 7 9238230723 4
Lots: All Lots
The hazard
The product was found to contain undeclared colloidal silver and lacked sterility assurance. The FDA classified the recall as Class I, indicating a reasonable probability that the use of the product will cause serious adverse health consequences or death.
Context
GovInfoNow's records show other recent recalls of similar products include Sterile Lubricant Dry Eye Relief Eye Drops (2026-09-11), TRP Gentle Eyes Lubricant Eye Drops (2026-08-20), and Thea Pharma Similasan Eye Drops (2026-04-23).
How to tell if you have this one
Check for Lubrisine eye drops in 30mL bottles with the manufacturer's address in Orem, Utah. The product was distributed by Results RNA, LLC, and all lots are affected.
Brand
Results RNA
Product
Lubrisine eye drops (polyethylene glycol 400 0.4% and Propylene glycol 0.3%), 30 ML bottle, Manufactured and
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Look for Lubrisine eye drops (30mL) with the manufacturer's address in Orem, Utah.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide within the United States” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2.1 years after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class I
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The recall states the product contains undeclared colloidal silver, which can compromise sterility. Results RNA advises checking the product and following the recall instructions.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0360-2019 (December 14, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0360-2019 to see it in context.
Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.